文献速递糖尿病

发展中国家1型和2型糖尿病患者抑郁症状高发:IDMPS研究结果

High Prevalence of Depressive Symptoms in Patients With Type 1 and Type 2 Diabetes in Developing Countries: Results From the International Diabetes Management Practices Study.
PubMed 文献 · Diabetes Care · 2021-05-07

IDMPS是一项跨国横断面研究,纳入21个国家9865例糖尿病患者,用PHQ-9评估抑郁症状。1型糖尿病抑郁症状(PHQ-9≥5)占30.7%;2型糖尿病仅用口服药者29.0%、口服药加胰岛素者36.6%、仅用胰岛素者46.7%。女性、并发症和低社会经济地位是独立相关因素。

要点

  • 发展中国家糖尿病患者抑郁症状普遍,1型占30.7%,2型各治疗亚组29.0%-46.7%
  • 仅用胰岛素的2型糖尿病患者抑郁症状比例最高(46.7%)
  • 女性、并发症和低社会经济地位与抑郁症状独立相关

核心结论

  • 发展中国家糖尿病患者抑郁症状常见,应常规筛查,尤其高危人群,以减轻糖尿病与抑郁的双重负担及负性交互。

研究设计与样本

  • IDMPS为正在进行的跨国横断面研究,评估真实世界糖尿病诊疗质量。
  • 分析第5波(2011年)数据,纳入21个国家9865例患者,其中1型2280例、2型7585例。
  • 使用9项患者健康问卷(PHQ-9)评估抑郁症状,并采用逻辑回归分析相关因素。

主要发现

  • 1型糖尿病患者抑郁症状(PHQ-9评分≥5)占30.7%。
  • 2型糖尿病仅用口服降糖药(OGLD)者抑郁症状占29.0%,OGLD加胰岛素者占36.6%,仅用胰岛素者占46.7%。
  • 1型或2型糖尿病患者中,中度抑郁症状(PHQ-9评分10-19)占8%-16%。
  • 女性、并发症和低社会经济地位与抑郁症状独立相关。
  • 在1型糖尿病和2型糖尿病仅用OGLD组中,抑郁与血糖控制不佳相关。

关键数值与推荐

  • 抑郁症状定义为PHQ-9评分≥5。
  • 中度抑郁症状定义为PHQ-9评分10-19。

临床怎么用

  • 对发展中国家糖尿病患者应常规筛查抑郁症状,尤其女性、有并发症或低社会经济地位者。
  • 对1型糖尿病和2型糖尿病仅用口服药且血糖控制不佳者,应关注抑郁症状。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Depression is common in people with diabetes, but data from developing countries are scarce. We evaluated the prevalence and risk factors for depressive symptoms in patients with diabetes using data from the International Diabetes Management Practices Study (IDMPS). RESEARCH DESIGN AND METHODS: IDMPS is an ongoing multinational, cross-sectional study investigating quality of care in patients with diabetes in real-world settings. Data from wave 5 (2011), including 21 countries, were analyzed using the 9-item Patient Health Questionnaire (PHQ-9) to evaluate depressive symptoms. Logistic regression analyses were conducted to identify risk factors of depressive symptoms. RESULTS: Of 9,865 patients eligible for analysis, 2,280 had type 1 and 7,585 had type 2 diabetes (treatment: oral glucose-lowering drugs [OGLD] only, n = 4,729; OGLDs plus insulin, n = 1,892; insulin only, n = 964). Depressive symptoms (PHQ-9 score ≥5) were reported in 30.7% of those with type 1 diabetes. In patients with type 2 diabetes, the respective figures were 29.0% for OGLDs-only, 36.6% for OGLDs-plus-insulin, and 46.7% for insulin-only subgroups. Moderate depressive symptoms (PHQ-9 score 10-19) were observed in 8-16% of patients with type 1 or type 2 diabetes. Female sex, complications, and low socioeconomic status were independently associated with depressive symptoms. In type 1 diabetes and in the type 2 diabetes OGLDs-only group, depression was associated with poor glycemic control. CONCLUSIONS: Depressive symptoms are common in patients with diabetes from developing countries, calling for routine screening, especially in high-risk groups, to reduce the double burden of diabetes and depression and their negative interaction.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Aschner P, Gagliardino JJ, Ilkova H, et al. High Prevalence of Depressive Symptoms in Patients With Type 1 and Type 2 Diabetes in Developing Countries: Results From the International Diabetes Management Practices Study. Diabetes Care. 2021. PMID: 33963019. doi:10.2337/dc20-2003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。